Literature DB >> 9371559

Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants.

K Saeki1, N Ohtsuka, F Taguchi.   

Abstract

We previously demonstrated by site-directed mutagenesis analysis that the amino acid residues at positions 62 and 214 to 216 in the N-terminal region of mouse hepatitis virus (MHV) spike (S) protein are important for receptor-binding activity (H. Suzuki and F. Taguchi, J. Virol. 70:2632-2636, 1996). To further identify the residues responsible for the activity, we isolated the mutant viruses that were not neutralized with the soluble form of MHV receptor proteins, since such mutants were expected to have mutations in amino acids responsible for receptor-binding activity. Five soluble-receptor-resistant (srr) mutants isolated had mutations in a single amino acid at three different positions: one was at position 65 (Leu to His) (srr11) in the S1 subunit and three were at position 1114 (Leu to Phe) (srr3, srr4, and srr7) and one was at position 1163 (Cys to Phe) (srr18) in the S2 subunit. The receptor-binding activity examined by a virus overlay protein blot assay and by a coimmunoprecipitation assay showed that srr11 S protein had extremely reduced binding activity, while the srr7 and srr18 proteins had binding activity similar to that of wild-type cl-2 protein. However, when cell surface receptors were used for the binding assay, all srr mutants showed activity similar to that of the wild type or only slightly reduced activity. These results, together with our previous observations, suggest that amino acids located at positions 62 to 65 of S1, a region conserved among the MHV strains examined, are important for receptor-binding activity. We also discuss the mechanism by which srr mutants with a mutation in S2 showed high resistance to neutralization by a soluble receptor, despite their sufficient level of binding to soluble receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371559      PMCID: PMC230203     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Difference in virus-binding activity of two distinct receptor proteins for mouse hepatitis virus.

Authors:  N Ohtsuka; Y K Yamada; F Taguchi
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

2.  Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture.

Authors:  N Hirano; K Fujiwara; S Hino; M Matumoto
Journal:  Arch Gesamte Virusforsch       Date:  1974

3.  Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages.

Authors:  F Taguchi; A Yamada; K Fujiwara
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

Review 4.  The biology and pathogenesis of coronaviruses.

Authors:  H Wege; S Siddell; V ter Meulen
Journal:  Curr Top Microbiol Immunol       Date:  1982       Impact factor: 4.291

5.  Proteolytic cleavage of peplomeric glycoprotein E2 of MHV yields two 90K subunits and activates cell fusion.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

6.  Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin.

Authors:  K V Holmes; E W Doller; J N Behnke
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

7.  Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM.

Authors:  F Taguchi; S G Siddell; H Wege; V ter Meulen
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein.

Authors:  Y K Yamada; K Takimoto; M Yabe; F Taguchi
Journal:  Virology       Date:  1997-01-06       Impact factor: 3.616

10.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

View more
  47 in total

1.  Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

Authors:  Kuo-Ming Lip; Shuo Shen; Xiaoming Yang; Choong-Tat Keng; Aihua Zhang; Hsueh-Ling Janice Oh; Zhi-Hong Li; Le-Ann Hwang; Chih-Fong Chou; Burtram C Fielding; Timothy H P Tan; Josef Mayrhofer; Falko G Falkner; Jianlin Fu; Seng Gee Lim; Wanjin Hong; Yee-Joo Tan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Cooperative involvement of the S1 and S2 subunits of the murine coronavirus spike protein in receptor binding and extended host range.

Authors:  Cornelis A M de Haan; Eddie Te Lintelo; Zhen Li; Matthijs Raaben; Tom Wurdinger; Berend Jan Bosch; Peter J M Rottier
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

3.  Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor.

Authors:  Robert J Ossiboff; Yi Zhou; Patrick J Lightfoot; B V Venkataram Prasad; John S L Parker
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

4.  Receptor-induced conformational changes of murine coronavirus spike protein.

Authors:  Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.

Authors:  D Yoo; D Deregt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Receptor-independent infection of murine coronavirus: analysis by spinoculation.

Authors:  Rie Watanabe; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

7.  Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism.

Authors:  Jung-Eun Park; Kun Li; Arlene Barlan; Anthony R Fehr; Stanley Perlman; Paul B McCray; Tom Gallagher
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

Review 8.  Coronavirus spike proteins in viral entry and pathogenesis.

Authors:  T M Gallagher; M J Buchmeier
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

9.  N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein.

Authors:  Hideka S Miura; Keiko Nakagaki; Fumihiro Taguchi
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein.

Authors:  Christelle Langevin; Christine Tuffereau
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.